What question did this study set out to answer?

This research aims to evaluate ONC206 as a potential treatment for high-risk medulloblastoma.

March 15, 2026

ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma

Key Points

This research aims to evaluate ONC206 as a potential treatment for high-risk medulloblastoma.
Evaluation of ONC206's anti-tumorigenic activity in medulloblastoma models.
Assessment of ONC206's effectiveness as a therapeutic strategy.
ONC206 demonstrates strong anti-tumorigenic properties.
Indicates potential as a novel treatment option for high-risk medulloblastoma patients.

Abstract

Our results highlight ONC206 as a novel therapeutic option for patients with high-risk medulloblastoma and provide strong rationale for testing the efficacy of ONC206 in the treatment of these patients.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Theophilos Tzaridis

Jingbo Liu

Franklin Chien

Journals

Neuro-Oncology

Actions

Institutions

Emory University

Columbia University Irving Medical Center

Discovery Institute

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider